| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,055 |
15,963 |
$371K |
| 90834 |
Psychotherapy, 45 minutes with patient |
2,298 |
1,274 |
$92K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,190 |
2,026 |
$73K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,845 |
2,720 |
$65K |
| 90686 |
|
2,043 |
2,038 |
$43K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,248 |
2,220 |
$39K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,215 |
2,443 |
$25K |
| 90837 |
Psychotherapy, 53 minutes with patient |
2,061 |
1,430 |
$24K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,221 |
1,200 |
$19K |
| 90670 |
|
732 |
721 |
$15K |
| 98968 |
|
430 |
291 |
$12K |
| 96152 |
|
733 |
495 |
$6K |
| 96127 |
|
1,264 |
1,174 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
218 |
214 |
$3K |
| 90698 |
|
175 |
170 |
$3K |
| 90791 |
Psychiatric diagnostic evaluation |
95 |
93 |
$3K |
| 90723 |
|
120 |
119 |
$2K |
| 90680 |
|
113 |
112 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
28 |
28 |
$2K |
| 90647 |
|
107 |
103 |
$2K |
| 0072A |
|
30 |
30 |
$2K |
| 90656 |
|
79 |
79 |
$2K |
| 90685 |
|
76 |
76 |
$2K |
| 90697 |
|
44 |
44 |
$965.80 |
| 0071A |
|
23 |
16 |
$920.00 |
| 90633 |
|
38 |
38 |
$768.38 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
54 |
40 |
$743.31 |
| 96150 |
|
59 |
58 |
$663.68 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
25 |
25 |
$614.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
25 |
25 |
$614.00 |
| 90677 |
|
26 |
26 |
$570.96 |
| 90734 |
|
22 |
12 |
$482.90 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
199 |
174 |
$363.75 |
| 90671 |
|
12 |
12 |
$241.56 |
| 99188 |
|
480 |
478 |
$221.95 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
231 |
213 |
$198.97 |
| 83655 |
|
76 |
69 |
$144.45 |
| 81025 |
|
64 |
64 |
$84.42 |
| 85018 |
|
97 |
90 |
$28.23 |
| 96151 |
|
69 |
50 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
15 |
15 |
$0.00 |
| 99024 |
|
33 |
26 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
12 |
12 |
$0.00 |